Beyond Air (XAIR) Income from Non-Controlling Interests (2021 - 2026)
Beyond Air (XAIR) reported Income from Non-Controlling Interests of -$86000.0 for Q1 2026, down 196.55% on a YoY basis from $89071.4 in Q1 2025, and up 70.75% sequentially from -$294000.0 in Q4 2025.
Beyond Air (XAIR) Income from Non-Controlling Interests (2021 - 2026) Analysis & Trends
Beyond Air (XAIR) has 6 years of Income from Non-Controlling Interests data on file, last reported at -$86000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Non-Controlling Interests fell 196.55% year-over-year to -$86000.0; the trailing twelve-month figure through Mar 2026 stood at -$1.1 million (up 41.48% YoY), and the FY2026 full-year result was -$1.1 million, up 41.48% from the prior year.
- Income from Non-Controlling Interests rose to -$86000.0 in Q1 2026, from -$294000.0 in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of -$29000.0 in Q1 2025 to a low of -$1.2 million in Q3 2023.
- A 5-year average of -$660882.4 and a median of -$720000.0 in 2022 frame the typical range for Income from Non-Controlling Interests.
- Across the five-year window, Income from Non-Controlling Interests sank 371.3% in 2022 and jumped 96.58% in 2025, its largest moves.
- Tracing XAIR's Income from Non-Controlling Interests over 5 years: stood at -$1.1 million in 2022, then increased by 1.24% to -$1.0 million in 2023, then jumped by 71.1% to -$300000.0 in 2024, then gained by 2.0% to -$294000.0 in 2025, then surged by 70.75% to -$86000.0 in 2026.
- Business Quant data shows XAIR's Income from Non-Controlling Interests at -$86000.0 in Q1 2026, -$294000.0 in Q4 2025, and -$318000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 22.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -5.85 Mn |
| 10 | Beyond Air | 2.23 Mn | -10.13 Mn | 94,000.00 | -86,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -86,000.00 |
| Dec 31, 2025 | -294,000.00 |
| Sep 30, 2025 | -318,000.00 |
| Jun 30, 2025 | -387,000.00 |
| Mar 31, 2025 | -29,000.00 |
| Dec 31, 2024 | -300,000.00 |
| Sep 30, 2024 | -671,000.00 |
| Jun 30, 2024 | -854,000.00 |
| Mar 31, 2024 | -849,000.00 |
| Dec 31, 2023 | -1.04 Mn |
| Sep 30, 2023 | -1.21 Mn |
| Jun 30, 2023 | -960,000.00 |
| Mar 31, 2023 | -984,000.00 |
| Dec 31, 2022 | -1.05 Mn |
| Sep 30, 2022 | -830,000.00 |
| Jun 30, 2022 | -720,000.00 |
| Mar 31, 2022 | -659,000.00 |
| Dec 31, 2021 | -223,000.00 |